News

NICE has approved the use of the drug fruquintinib (Fruzaqla) for eligible advanced bowel cancer patients living in England and Wales.
In 2023 we launched our bold new five-year strategy 'On a Mission', we knew it was ambitious, but achievable. Today we’ve published our Annual Report and Accounts 2024, and it’s clear the year marks a ...
Dr Lisa Wilde, Director of Research, Policy and Influencing, shares her reflections from the Global Early-Onset Colorectal Cancer Think Tank (GEOCRCTT) in Barcelona.
The Government has published its 10 Year Health Plan, following a consultation to shape the future of the NHS in England.
We’re excited to invite North East Lincolnshire locals to walk inside a giant inflatable bowel to raise awareness of bowel cancer and its symptoms.
Read more about our current projects partnering with leading clinicians, institutions and academics across the UK.
We’re the UK’s leading bowel cancer charity. We’re determined to save lives and improve the quality of life of everyone affected by bowel cancer.